期刊论文详细信息
BMC Gastroenterology
Hepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity
Frank J Burczynski1  Yufei Chen2  Jing Yan2  Yuewen Gong2  Guqi Wang3  Yu Gong2 
[1] Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada;Faculty of Pharmacy, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada;Liver-Biliary-Pancreatic Center, Carolinas Medical Center Charlotte, Charlotte, NC 28232-2861, USA
关键词: Apoptosis;    Liver;    Oxidative stress;    Acetaminophen;    FABP1;   
Others  :  855677
DOI  :  10.1186/1471-230X-14-44
 received in 2013-04-30, accepted in 2014-03-03,  发布年份 2014
PDF
【 摘 要 】

Background

FABP1 has been reported to possess strong antioxidant properties. Upon successful transfection of the Chang cell line, which has undetectable FABP1 mRNA levels, with human FABP1 cDNA, the Chang cells were shown to express FABP1. Using the transfected and control (normal) Chang cells and subjecting them to oxidative stress, transfected cells were reported to be associated with enhanced cell viability. This study extends those observations by investigating the effect of FABP1 on acetaminophen (AAP)-induced hepatotoxicity. We hypothesized that presence of FABP1 would enhance cell viability compared to control cells (vector transfected cells).

Methods

Following AAP treatment of Chang FABP1 transfected and control cells, cell viability, oxidative stress, and apoptosis were evaluated using lactate dehydrogenase (LDH) release, the fluorescent probe DCF, and Bax expression, respectively.

Results

FABP1 cDNA transfected cells showed greater resistance against AAP toxicity than vector transfected cells. Significantly lower LDH levels (p < 0.05) were observed as were lower DCF fluorescence intensity (p < 0.05) in FABP1 cDNA transfected cells compared to vector transfected cells. FABP1 expression also attenuated the expression of Bax following AAP induced toxicity.

Conclusion

FABP1 attenuated AAP-induced toxicity and may be considered a cytoprotective agent in this in vitro model of drug induced oxidative stress.

【 授权许可】

   
2014 Gong et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140722055326141.pdf 344KB PDF download
42KB Image download
78KB Image download
50KB Image download
48KB Image download
53KB Image download
【 图 表 】

【 参考文献 】
  • [1]Levi AJ, Gatmaitan Z, Arias IM: Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J Clin Invest 1969, 48(11):2156-2167.
  • [2]Bordewick U, Heese M, Borchers T, Robenek H, Spener F: Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis. Biol Chem Hoppe-Seyler 1989, 370(3):229-238.
  • [3]Fahimi HD, Voelkl A, Vincent SH, Muller-Eberhard U: Localization of the heme-binding protein in the cytoplasm and of a heme-binding protein-like immunoreactive protein in the nucleus of rat liver parenchymal cells: immunocytochemical evidence of the subcellular distribution corroborated by radioimmunoassay and immunoblotting. Hepatology 1990, 11(5):859-865.
  • [4]Wolfrum C, Borchers T, Sacchettini JC, Spener F: Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry 2000, 39:1469-1474.
  • [5]Wang G, Gong Y, Anderson J, Sun D, Minuk G, Roberts MS, Burczynski FJ: Antioxidative Function of L-FABP in L-FABP Stable Transfected Chang Liver Cells. Hepatology 2005, 42:871-879.
  • [6]Wang G, Shen H, Rajaraman G, Roberts MS, Gong Y, Jiang P, Burczynski F: Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Eur J Pharmacol 2007, 560:61-68.
  • [7]Bassuk JA, Tsichlis PN, Sorof S: Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes. Proc Natl Acad Sci USA 1987, 84:7547-7551.
  • [8]Lee WM: Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004, 40(1):6-9.
  • [9]Nelson SD: Metabolic activation and drug toxicity. J Med Chem 1982, 25(7):753-765.
  • [10]Chen C, Hennig GE, Manautou JE: Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats. Drug Metab Dispos 2003, 31(6):798-804.
  • [11]Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB: Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 1973, 187(1):195-202.
  • [12]Shon YH, Nam KS: Protective effect of moutan cortex extract on acetaminophen-induced cytotoxicity in human Chang liver cells. Biol Pharm Bull 2002, 25(11):1427-1431.
  • [13]Meyers LL, Beierschmitt WP, Khairallah EA, Cohen SD: Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. Toxicol Appl Pharmacol 1988, 93(3):378-387.
  • [14]Ramsay RR, Rashed MS, Nelson SD: In vitro effects of acetaminophen metabolites and analogs on the respiration of mouse liver mitochondria. Arch Biochem Biophys 1989, 273(2):449-457.
  • [15]Jaeschke H: Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther 1990, 255(3):935-941.
  • [16]Tirmenstein MA, Nelson SD: Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides. J Biol Chem 1990, 265(6):3059-3065.
  • [17]Masubuchi Y, Suda C, Horie T: Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 2005, 42(1):110-116.
  • [18]Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke H: Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 2001, 62(2):212-220.
  • [19]Ek-Von Mentzer BA, Zhang F, Hamilton JA: Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. J Biol Chem 2001, 276(19):15575-15580.
  • [20]Raza H, Pongubala JR, Sorof S: Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein. Biochem Biophys Res Commun 1989, 161(2):448-455.
  • [21]Yan J, Gong Y, She YM, Wang G, Roberts MS, Burczynski FJ: Molecular mechanism of recombinant liver fatty acid binding protein’s antioxidant activity. J Lipid Res 2009, 50(12):2445-2454.
  • [22]Thumser AEA, Storch J: Liver and intestinal fatty acid-binding proteins obtain fatty acids from phospholipid membranes by different mechanisms. J Lipid Res 2000, 41(4):647-656.
  • [23]Bajt ML, Knight TR, Lemasters JJ, Jaeschke H: Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol Sci 2004, 80(2):343-349.
  • [24]Bernas T, Dobrucki J: Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry 2002, 47(4):236-242.
  • [25]Huet O, Petit JM, Ratinaud MH, Julien R: NADH-dependent dehydrogenase activity estimation by flow cytometric analysis of 3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. Cytometry 1992, 13(5):532-539.
  • [26]Whelan RS, Konstantinidis K, Wei AC, Chen Y, Reyna DE, Jha S, Yang Y, Calvert JW, Lindsten T, Thompson CB, Crow MT, Gavathiotis E, Dorn GW, O’Rourke B, Kitsis RN: Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci USA 2012, 109(17):6566-6571.
  • [27]Karch J, Kwong JQ, Burr AR, Sargent MA, Elrod JW, Peixoto PM, Martinez-Caballero S, Osinska H, Cheng EH, Robbins J, Kinnally KW, Molkentin JD: Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. eLife 2013, 2:e00772.
  • [28]Bajt ML, Farhood A, Lemasters JJ, Jaeschke H: Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity. J Pharmacol Exp Ther 2008, 324(1):8-14.
  • [29]Lemasters JJ: V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol 1999, 276(1 Pt 1):G1-G6.
  文献评价指标  
  下载次数:91次 浏览次数:30次